Effect of Statins on Serum Prostate-specific Antigen Levels.

[1]  T. Tammela,et al.  Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial , 2010, International journal of cancer.

[2]  E. Platz,et al.  Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001–2004 , 2010, Cancer Causes & Control.

[3]  E. Platz,et al.  The influence of statin medications on prostate-specific antigen levels. , 2008, Journal of the National Cancer Institute.

[4]  J. Stanford,et al.  Statin use and risk of prostate cancer: results from a population-based epidemiologic study. , 2008, American journal of epidemiology.

[5]  B. Sternfeld,et al.  Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort , 2007, Cancer Epidemiology Biomarkers & Prevention.

[6]  T. Tammela,et al.  Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[7]  T. Travison,et al.  Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey , 2007, Cancer Epidemiology Biomarkers & Prevention.

[8]  E. Rimm,et al.  Statin drugs and risk of advanced prostate cancer. , 2006, Journal of the National Cancer Institute.

[9]  C Michael White,et al.  Statins and Cancer Risk: A Meta-analysis , 2007 .

[10]  M. Garzotto,et al.  Statins and prostate cancer risk: a case-control study. , 2005, American journal of epidemiology.

[11]  D. Kadmon,et al.  The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. , 2005, The Journal of urology.

[12]  Ronit Almog,et al.  Statins and the risk of colorectal cancer. , 2005, The New England journal of medicine.

[13]  Jayoung Kim,et al.  Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. , 2005, The Journal of clinical investigation.

[14]  R. Madhok,et al.  Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial , 2004, The Lancet.

[15]  Henk-Jan Guchelaar,et al.  The risk of cancer in users of statins. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  V. Durkalski,et al.  Oral simvastatin treatment in relapsing-remitting multiple sclerosis , 2004, The Lancet.

[17]  B. Kaina,et al.  Lovastatin inhibits Rho‐regulated expression of E‐selectin by TNF‐α and attenuates tumor cell adhesion , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  T. Toyo-Oka,et al.  Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development , 2003, Circulation research.

[19]  S. Youssef,et al.  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease , 2002, Nature.

[20]  C. Heeschen,et al.  Statins Have Biphasic Effects on Angiogenesis , 2002, Circulation.

[21]  M. Tatsuta,et al.  Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. , 2001, Cancer research.

[22]  H Jick,et al.  Statins and the risk of dementia , 2000, The Lancet.

[23]  K. Keyomarsi,et al.  Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W C Willett,et al.  Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.

[25]  D. Tindall,et al.  Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. , 1991, Cancer research.

[26]  W. Rom,et al.  In Vitro Mechanisms of Lovastatin on Lung Cancer Cell Lines as a Potential Chemopreventive Agent , 2007, Lung.

[27]  P. Loehrer.  Statins and Cancer Risk: A Meta-analysis , 2007 .

[28]  M. Freeman,et al.  Cholesterol and prostate cancer , 2004, Journal of cellular biochemistry.